Coronavirus News Roundup: Moderna Increases Production Estimates for COVID-19 Vaccine, FDA Warns Against Changes to Vaccine Dosing Schedules
Here’s a roundup of the latest coronavirus-related news.
The number of coronavirus disease 2019 (COVID-19) cases in the United States continue to surge, with a weekly average of 266,000 daily cases and an estimated 132,000 COVID-19––related hospitalizations as of January 7, according to The COVID Tracking Project.
Here’s a roundup of the latest coronavirus-related news:
IDSA Releases Revised Guidelines for COVID-19 Diagnostic Testing
In a briefing on Wednesday, Infectious Diseases Society of America (IDSA) board of directors members discussed revised recommendations for COVID-19 diagnostic testing.
Moderna Increases Production Estimates for COVID-19 Vaccine
Moderna is increasing the estimated number of doses of its COVID-19 vaccine that it expects to produce to 600 million for 2021, according to a company statement.
FDA Warns Against Changes to Authorized Dosing Schedules of COVID-19 Vaccines
Officials with the FDA took a stance on the authorized dosing schedules for COVID-19 vaccines, stating that all health care professionals should continue to administer 2 full doses of the vaccine, according to a statement.
Novavax Announces Phase 3 Study for COVID-19 Vaccine Candidate
Biotechnology company Novavax has announced the start of its phase 3 study evaluating a vaccine candidate for COVID-19.
Addressing SDoH, COVID-19 Vaccine at BCBS Minnesota
In this final part of a 3-part video series, Craig Samitt, CEO and president of Blue Cross Blue Shield of Minnesota talks with Managed Healthcare Executive about their focus on social determinants of health and the COVID-19 vaccine.
